237 related articles for article (PubMed ID: 32736520)
21. LncRNA RPPH1 attenuates Aβ
Gu R; Liu R; Wang L; Tang M; Li SR; Hu X
Int J Neurosci; 2021 May; 131(5):425-432. PubMed ID: 32336203
[TBL] [Abstract][Full Text] [Related]
22. p21-activated kinase 2 binds to transcription factor SOX2 and up-regulates DEK to promote the progression of lung squamous cell carcinoma.
Xie S; Wan X; Chen S; Hu Y; Liu X
Lab Invest; 2022 Oct; 102(10):1109-1120. PubMed ID: 35821094
[TBL] [Abstract][Full Text] [Related]
23. Knockdown of long non-coding RNA SOX21-AS1 attenuates amyloid-β-induced neuronal damage by sponging miR-107.
Xu W; Li K; Fan Q; Zong B; Han L
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32124921
[TBL] [Abstract][Full Text] [Related]
24. Secreted nuclear protein DEK regulates hematopoiesis through CXCR2 signaling.
Capitano ML; Mor-Vaknin N; Saha AK; Cooper S; Legendre M; Guo H; Contreras-Galindo R; Kappes F; Sartor MA; Lee CT; Huang X; Markovitz DM; Broxmeyer HE
J Clin Invest; 2019 May; 129(6):2555-2570. PubMed ID: 31107242
[TBL] [Abstract][Full Text] [Related]
25. Long Noncoding RNA NEAT1 Aggravates Aβ-Induced Neuronal Damage by Targeting miR-107 in Alzheimer's Disease.
Ke S; Yang Z; Yang F; Wang X; Tan J; Liao B
Yonsei Med J; 2019 Jul; 60(7):640-650. PubMed ID: 31250578
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic transcripts of LINC01311 and hsa-miR-146a-5p regulate neural development in a cellular model of Alzheimer's disease.
Fan Y; Zhang J; Zhuang X; Geng F; Jiang G; Yang X
IUBMB Life; 2021 Jul; 73(7):916-926. PubMed ID: 33830627
[TBL] [Abstract][Full Text] [Related]
27. [Effects of miR-144 on proliferation, apoptosis and cisplatin resistance by targeting MYCN in pediatric neuroblastoma].
Liu HJ; Li GL; Lei PC
Zhonghua Zhong Liu Za Zhi; 2019 Jul; 41(7):516-521. PubMed ID: 31357838
[No Abstract] [Full Text] [Related]
28. MiR-485-3p serves as a biomarker and therapeutic target of Alzheimer's disease via regulating neuronal cell viability and neuroinflammation by targeting AKT3.
Yu L; Li H; Liu W; Zhang L; Tian Q; Li H; Li M
Mol Genet Genomic Med; 2021 Jan; 9(1):e1548. PubMed ID: 33220166
[TBL] [Abstract][Full Text] [Related]
29. Role of the DEK oncogene in the development of squamous cell carcinoma.
Ishida K; Nakashima T; Shibata T; Hara A; Tomita H
Int J Clin Oncol; 2020 Sep; 25(9):1563-1569. PubMed ID: 32656741
[TBL] [Abstract][Full Text] [Related]
30. Bacterial Growth Inhibition Screen (BGIS) identifies a loss-of-function mutant of the DEK oncogene, indicating DNA modulating activities of DEK in chromatin.
Guo H; Prell M; Königs H; Xu N; Waldmann T; Hermans-Sachweh B; Ferrando-May E; Lüscher B; Kappes F
FEBS Lett; 2021 May; 595(10):1438-1453. PubMed ID: 33686684
[TBL] [Abstract][Full Text] [Related]
31. DEK oncogene is overexpressed during melanoma progression.
Riveiro-Falkenbach E; Ruano Y; García-Martín RM; Lora D; Cifdaloz M; Acquadro F; Ballestín C; Ortiz-Romero PL; Soengas MS; Rodríguez-Peralto JL
Pigment Cell Melanoma Res; 2017 Mar; 30(2):194-202. PubMed ID: 27893188
[TBL] [Abstract][Full Text] [Related]
32. Silencing DEK downregulates cervical cancer tumorigenesis and metastasis via the DEK/p-Ser9-GSK-3β/p-Tyr216-GSK-3β/β-catenin axis.
Xu X; Zou L; Yao Q; Zhang Y; Gan L; Tang L
Oncol Rep; 2017 Aug; 38(2):1035-1042. PubMed ID: 28627610
[TBL] [Abstract][Full Text] [Related]
33. Forced expression of the DEK-NUP214 fusion protein promotes proliferation dependent on upregulation of mTOR.
Sandén C; Ageberg M; Petersson J; Lennartsson A; Gullberg U
BMC Cancer; 2013 Sep; 13():440. PubMed ID: 24073922
[TBL] [Abstract][Full Text] [Related]
34. Computational identification and experimental validation of microRNAs binding to the Alzheimer-related gene ADAM10.
Augustin R; Endres K; Reinhardt S; Kuhn PH; Lichtenthaler SF; Hansen J; Wurst W; Trümbach D
BMC Med Genet; 2012 May; 13():35. PubMed ID: 22594617
[TBL] [Abstract][Full Text] [Related]
35. The emerging role of microRNA-4487/6845-3p in Alzheimer's disease pathologies is induced by Aβ25-35 triggered in SH-SY5Y cell.
Hu L; Zhang R; Yuan Q; Gao Y; Yang MQ; Zhang C; Huang J; Sun Y; Yang W; Yang JY; Min ZL; Cheng J; Deng Y; Hu X
BMC Syst Biol; 2018 Dec; 12(Suppl 7):119. PubMed ID: 30547775
[TBL] [Abstract][Full Text] [Related]
36. Neuronal Dynamics and miRNA Signaling Differ between SH-SY5Y
Garcia G; Pinto S; Cunha M; Fernandes A; Koistinaho J; Brites D
Cells; 2021 Sep; 10(9):. PubMed ID: 34572073
[TBL] [Abstract][Full Text] [Related]
37. DEK is a poly(ADP-ribose) acceptor in apoptosis and mediates resistance to genotoxic stress.
Kappes F; Fahrer J; Khodadoust MS; Tabbert A; Strasser C; Mor-Vaknin N; Moreno-Villanueva M; Bürkle A; Markovitz DM; Ferrando-May E
Mol Cell Biol; 2008 May; 28(10):3245-57. PubMed ID: 18332104
[TBL] [Abstract][Full Text] [Related]
38. miR-16-5p and miR-19b-3p prevent amyloid β-induced injury by targeting BACE1 in SH-SY5Y cells.
Zhang N; Li WW; Lv CM; Gao YW; Liu XL; Zhao L
Neuroreport; 2020 Feb; 31(3):205-212. PubMed ID: 31876684
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of JAK1 by microRNA-708 promotes SH-SY5Y neuronal cell survival after oxygen and glucose deprivation and reoxygenation.
Huang C; Zhou H; Ren X; Teng J
Neurosci Lett; 2018 Jan; 664():43-50. PubMed ID: 29128627
[TBL] [Abstract][Full Text] [Related]
40. The unique DEK oncoprotein in women's health: A potential novel biomarker.
de Albuquerque Oliveira AC; Kappes F; Martins DBG; de Lima Filho JL
Biomed Pharmacother; 2018 Oct; 106():142-148. PubMed ID: 29957464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
